組織工程市場規模、佔有率及成長分析（按類型、應用、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，組織工程市場規模將達到 50.9 億美元，到 2025 年將達到 58.7 億美元，到 2033 年將達到 182.3 億美元，在預測期（2026-2033 年）內，複合年成長率為 15.23%。

組織工程產業正經歷顯著成長，這主要得益於生物材料知識的不斷豐富、技術的進步以及對再生醫學解決方案日益成長的需求。這些因素透過提供組織修復和再生方面的創新選擇，顯著提升了醫療保健水準。一個值得關注的趨勢是再生醫學的應用範圍不斷擴大，其重點在於利用生物構建體修復和重建受損組織和器官，凸顯了組織工程在再生醫學中的核心作用。器官晶片技術的引進能夠精確模擬人體器官功能，並創造一個安全的實驗環境。生物技術公司、醫療機構和研究機構之間日益緊密的合作正在推動組織工程產品的商業化。監管政策的完善正在簡化市場准入流程，而牙科組織工程等專業領域也日益受到關注。

組織工程市場促進因素

全球組織工程市場的主要促進因素之一是慢性疾病和損傷的日益增多，這些疾病和損傷需要先進的治療方案。全球人口老化和文明病的增加，推動了對能夠再生受損組織和器官的創新治療方法的需求。組織工程技術結合了生物材料和生物成分，以促進組織再生，為傳統外科手術提供了極具前景的替代方案。此外，研發投入的不斷增加以及幹細胞技術和3D生物列印技術的進步，使得更有效、更個人化的再生醫學成為可能，進一步推動了這個充滿活力的市場的成長。

組織工程市場面臨的限制

全球組織工程領域的主要市場限制因素之一是組織工程產品的研發、監管核准和生產流程高成本。這些費用會阻礙中小企業進入市場，限制創新，並削弱競爭。此外，監管障礙和新治療方法漫長的核准流程也會減緩利害關係人相關人員對報銷政策和臨床療效存在不確定性。這種經濟負擔構成了阻礙，限制了先進組織工程解決方案在醫療保健市場的成長和商業化。

組織工程市場趨勢

組織工程市場正經歷重大變革，而推動這項變革的正是3D生物列印技術的日益普及。這項創新技術能夠精確建構複雜的組織結構，進而促進功能性、個人化組織建構體的開發。結合生物材料和列印技術的進步，3D生物列印正在簡化再生醫學領域，有效縮短產品開發週期，並改善患者預後。隨著研究的深入和應用範圍的擴大，這一趨勢預計將加速發展，促進跨行業合作，並增加醫學領域突破性治療方案的潛力。

目錄

介紹

• 調查目標
• 定義
• 市場覆蓋範圍

調查方法

• 資訊收集
• 二手和一手資料資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

前景
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 抑制因素
  • 任務
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 定價分析
• 價值鏈分析
• 供應鏈分析
• 技術分析
• 專利分析
• 監管環境
• 客戶和購買標準分析

組織工程市場：依產品分類

• 鷹架
  • 合成支架
  • 生物來源支架
  • 膠原蛋白蛋白支架
  • 基於水凝膠的支架
  • 基於幹細胞的支架
  • 其他生物來源支架
• 組織移植
  • 同種異體移植
  • 自體移植
  • 合成接枝
  • 異質骨移植
• 其他產品

組織工程市場：依材料分類

• 合成材料
• 生物來源材料

組織工程市場：依應用領域分類

• 整形外科和肌肉骨骼疾病
• 皮膚病學和創傷護理
• 牙科疾病
• 心血管疾病
• 其他用途

組織工程市場（按最終用戶分類）

• 醫院
• 專業中心和診所
• 門診手術中心

組織工程市場：按地區分類的市場規模：

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市佔率（2025 年）

主要企業簡介

• Organogenesis Inc.
• AbbVie Inc.
• MiMedx Group, Inc.
• Johnson & Johnson Services, Inc.
• B. Braun SE
• NuVasive, Inc.
• WL Gore & Associates, Inc.
• Zimmer Biomet
• Collplant Biotechnologies Ltd.
• Sumitomo Pharma Co., Ltd.
• Regrow Biosciences Pvt. Ltd.
• Tecnoss SRL
• Integra Lifesciences
• Smith & Nephew Plc
• Baxter
• BD
• Teijin Limited
• Institut Straumann Ag
• Medtronic
• Stryker
• Terumo Corporation
• Zimmer Biomet
• TissueTech
• Matricel Gmbh
• Mallinckrodt
• Vericel Corporation
• Tegoscience
• Tissue Regenix

Tissue Engineering Market size was valued at USD 5.09 Billion in 2024 and is poised to grow from USD 5.87 Billion in 2025 to USD 18.23 Billion by 2033, growing at a CAGR of 15.23% during the forecast period (2026-2033).

The tissue engineering industry is experiencing remarkable growth driven by enhanced knowledge of biomaterials, technological advancements, and rising demands for regenerative medicine solutions. These factors significantly improve healthcare by offering innovative options for tissue repair and restoration. A prominent trend is the rising application of regenerative medicine, focusing on restoring or reconstructing damaged tissues and organs through living constructs, underscoring the central role of tissue engineering in regenerative therapies. The introduction of organ-on-a-chip technology allows precise mimicry of human organ functions, promoting safe experimentation. The commercialization of tissue-engineered products is gaining traction, aided by stronger collaborations among biotechnology firms, healthcare providers, and research institutions. Regulatory advancements are simplifying market access, while specialized areas like dental tissue engineering are gaining increasing attention.

Top-down and bottom-up approaches were used to estimate and validate the size of the Tissue Engineering market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Tissue Engineering Market Segments Analysis

Global Tissue Engineering Market is segmented by Product, Material, Application, End User, and Region. Based on Product, the market is segmented into Scaffolds (Synthetic Scaffolds, Biological Scaffolds (Collagen-Based Scaffolds, Hydrogel-Based Scaffolds, Stem Cell-Based Scaffolds, Other Biological Material-Based Scaffolds)), Tissue Grafts (Allografts, Autografts, Synthetic Grafts, Xenografts), Other Products. Based on Material, the market is segmented into Synthetic Materials, Biologically Derived Materials. Based on Application, the market is segmented into Orthopedic & Musculoskeletal Disorders, Dermatology & Wound Care, Dental Disorders, Cardiovascular Diseases, Other Applications. Based on End User, the market is segmented into Hospitals, Specialty Centers & Clinics, Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Tissue Engineering Market

One of the key market drivers for the global tissue engineering market is the increasing prevalence of chronic diseases and injuries that necessitate advanced therapeutic solutions. As the global population ages and lifestyle-related ailments rise, there is a growing demand for innovative treatments that can regenerate damaged tissues and organs. Tissue engineering technologies, which combine biomaterials and biological components to foster tissue regeneration, present promising alternatives to traditional surgical procedures. Additionally, the rising investment in research and development, along with advancements in stem cell technology and 3D bioprinting, further propels the growth of this dynamic market by enabling more effective and personalized regenerative therapies.

Restraints in the Tissue Engineering Market

One significant market restraint for the global tissue engineering sector is the high cost associated with research and development, regulatory approvals, and the manufacturing processes required for producing tissue engineered products. These expenses can hinder market entry for small and medium-sized enterprises, limiting innovation and reducing competition. Additionally, regulatory hurdles and the lengthy approval process for new therapies may slow the adoption of tissue engineering technologies, as stakeholders face uncertainty regarding reimbursement policies and clinical efficacy. This financial burden creates barriers that can impede the growth and commercialization of advanced tissue engineering solutions in the healthcare market.

Market Trends of the Tissue Engineering Market

The Tissue Engineering market is witnessing a significant shift driven by the increased adoption of 3D bioprinting technologies. This innovation enables the precise construction of complex tissue structures, leading to enhanced development of functional and personalized tissue constructs. Coupled with advancements in biomaterials and printing techniques, 3D bioprinting is streamlining the regenerative medicine landscape, effectively reducing product development cycles and improving patient outcomes. As research progresses and applications expand, this trend is expected to accelerate, fostering collaboration across industries and enhancing the potential for breakthrough therapeutic solutions in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Pricing Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Technology Analysis
• Patent Analysis
• Regulatory Landscape
• Customer & Buying Criteria Analysis

Tissue Engineering Market, By Product

• Market Overview
• Scaffolds
  • Synthetic Scaffolds
  • Biological Scaffolds
  • Collagen-Based Scaffolds
  • Hydrogel-Based Scaffolds
  • Stem Cell-Based Scaffolds
  • Other Biological Material-Based Scaffolds
• Tissue Grafts
  • Allografts
  • Autografts
  • Synthetic Grafts
  • Xenografts
• Other Products

Tissue Engineering Market, By Material

• Market Overview
• Synthetic Materials
• Biologically Derived Materials

Tissue Engineering Market, By Application

• Market Overview
• Orthopedic & Musculoskeletal Disorders
• Dermatology & Wound Care
• Dental Disorders
• Cardiovascular Diseases
• Other Applications

Tissue Engineering Market, By End User

• Market Overview
• Hospitals
• Specialty Centers & Clinics
• Ambulatory Surgery Centers

Tissue Engineering Market Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Organogenesis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiMedx Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collplant Biotechnologies Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sumitomo Pharma Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regrow Biosciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecnoss S.R.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teijin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Institut Straumann Ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TissueTech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matricel Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vericel Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tegoscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissue Regenix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments